NFKB1 and cancer: NF-κB activation is regulated by proteasomes, which are an attractive target for cancer therapy, as the proteasome plays a central role in the regulation of proteins that modulate cell cycle progression, cell survival, migration and direct induction of apoptosis (10,11).